Legend Biotech Corp (LEGN) Total liabilities 2019–2024
Legend Biotech Corp (LEGN) total liabilities at each fiscal year-end, per SEC filings.
$629.7MFY2024 · since FY2019: $410.6M → $629.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $629.7M | +5.4% |
| FY2023 | $597.2M | +1.8% |
| FY2022 | $586.7M | +65.9% |
| FY2021 | $353.5M | +184.4% |
| FY2020 | $124.3M | -69.7% |
| FY2019 | $410.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice